---
figid: PMC4391119__13148_2014_92_Fig6_HTML
figlink: /pmc/articles/PMC4391119/figure/Fig6/
number: Figure 6
caption: Schematic summary of findings. Leucine supplementation promotes hepatic cell
  glucose uptake by upregulating solute carrier family member2 (SLC2A2) expression
  via myostatin (MSTN). MSTN activity leads to the activation of AMP- activated protein
  kinase (AMPK) and inhibition of glycogen synthesis. Furthermore, activation of MSTN
  leads to overexpression of genes involved in glucose uptake, which is further responsible
  for triglyceride synthesis. Moreover, leucine supplementation alters the expression
  of several small RNA species including miR-143, miR-335 and miR-92b*, which target
  main gene regulators of these effects.
pmcid: PMC4391119
papertitle: Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated
  protein kinase pathway - potential implications for nonalcoholic fatty liver disease.
reftext: Aida Zarfeshani, et al. Clin Epigenetics. 2014;6(1):27.
pmc_ranked_result_index: '69057'
pathway_score: 0.9426253
filename: 13148_2014_92_Fig6_HTML.jpg
figtitle: Schematic summary of findings
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4391119__13148_2014_92_Fig6_HTML.html
  '@type': Dataset
  description: Schematic summary of findings. Leucine supplementation promotes hepatic
    cell glucose uptake by upregulating solute carrier family member2 (SLC2A2) expression
    via myostatin (MSTN). MSTN activity leads to the activation of AMP- activated
    protein kinase (AMPK) and inhibition of glycogen synthesis. Furthermore, activation
    of MSTN leads to overexpression of genes involved in glucose uptake, which is
    further responsible for triglyceride synthesis. Moreover, leucine supplementation
    alters the expression of several small RNA species including miR-143, miR-335
    and miR-92b*, which target main gene regulators of these effects.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - SLC2A2
  - GPAM
  - BCL2A1
  - AKT2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - FOXO1
  - PRKAB2
  - PRKAG3
  - PRKAG1
  - PRKAG2
  - ACACA
  - ACACB
  - FOXA2
  - MSTN
  - AKT1
  - Glucose-6-P
  - glucose
  - Glycerol-3-P
  - Leucine
  - Triglyceride
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: GLUT2
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: GPAT1
  symbol: GPAT1
  source: hgnc_alias_symbol
  hgnc_symbol: GPAM
  entrez: '57678'
- word: ACC1
  symbol: ACC-1
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2A1
  entrez: '597'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: FOXA2
  symbol: FOXA2
  source: hgnc_symbol
  hgnc_symbol: FOXA2
  entrez: '3170'
- word: MSTN
  symbol: MSTN
  source: hgnc_symbol
  hgnc_symbol: MSTN
  entrez: '2660'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: Glucose-6-P
  source: MESH
  identifier: D005947
- word: glucose
  source: MESH
  identifier: D005947
- word: Glycerol-3-P
  source: MESH
  identifier: D005990
- word: Leucine
  source: MESH
  identifier: D007930
- word: Triglyceride
  source: MESH
  identifier: D014280
diseases: []
---
